Sanofi and GSK launch trial for COVID-19 protein-based vaccine
Posted by
www.biotecnika.org
Sanofi and GSK said in a joint statement on Thursday they had started
the "Phase 1/2" trial for their adjuvanted COVID-19 vaccine, which
they hope to make available across the world.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/sanofi-and-gsk-launch-trial-for-covid-19-protein-based-vaccine/articleshow/77905044.cms
Subscribe to:
Post Comments (Atom)
Post a Comment